Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tarsus Pharmaceuticals, Inc. - Common Stock
(NQ:
TARS
)
75.87
+3.22 (+4.43%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tarsus Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements
May 01, 2025
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Earnings Scheduled For May 1, 2025
↗
May 01, 2025
Via
Benzinga
An Overview of Tarsus Pharmaceuticals's Earnings
↗
April 30, 2025
Via
Benzinga
Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
April 24, 2025
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Would Mark Minervini consider TARSUS PHARMACEUTICALS INC (NASDAQ:TARS) a top stock pick?
↗
April 23, 2025
Exploring high growth characteristics of TARSUS PHARMACEUTICALS INC (NASDAQ:TARS). A fundamental and technical analysis of (NASDAQ:TARS).
Via
Chartmill
Earnings Scheduled For February 25, 2025
↗
February 25, 2025
Via
Benzinga
A Glimpse Into The Expert Outlook On Tarsus Pharmaceuticals Through 4 Analysts
↗
January 27, 2025
Via
Benzinga
Earnings Scheduled For November 13, 2024
↗
November 13, 2024
Via
Benzinga
Earnings Outlook For Tarsus Pharmaceuticals
↗
November 12, 2024
Via
Benzinga
Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting
April 22, 2025
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Why Mark Minervini may look into TARSUS PHARMACEUTICALS INC (NASDAQ:TARS)
↗
April 01, 2025
A fundamental and technical analysis of (NASDAQ:TARS): Why the high growth investor may take a look at TARSUS PHARMACEUTICALS INC (NASDAQ:TARS).
Via
Chartmill
Tarsus Announces Pricing of Upsized $125.0 Million Public Offering
March 12, 2025
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Announces Proposed $100.0 Million Public Offering
March 12, 2025
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus to Participate in Upcoming Investor Conference
March 06, 2025
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025
February 20, 2025
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus to Participate in Upcoming Investor Conferences
January 30, 2025
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care
January 13, 2025
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
How Tarsus Pharmaceuticals' Unique Inspiration Is Driving A Triple-Digit Run
↗
December 26, 2024
The company sells one drug to treat a condition that causes dry, red and itchy eyes. But rosacea and Lyme disease could be next.
Via
Investor's Business Daily
Disney To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday
↗
November 15, 2024
Via
Benzinga
Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
November 13, 2024
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors
November 13, 2024
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
November 06, 2024
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer
November 05, 2024
Dr. Yeu transitions from her role as Chief Medical Advisor and Board Member to lead the Company’s newly created Medical Organization
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
↗
October 28, 2024
Via
Benzinga
Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25%
October 17, 2024
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024
September 25, 2024
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference
August 28, 2024
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
TARS Stock Earnings: Tarsus Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
↗
August 08, 2024
TARS stock results show that Tarsus Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
August 08, 2024
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
July 29, 2024
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
